Equality Impact Assessment (Guidance development) (PDF 221 KB)
History
Documents created during the development process.
Expected publication
Final appraisal determination
Invitation to participate
Draft scope documents
Rheumatoid arthritis tofacitinib [ID526]: draft scope for consultation (pre-referral) - November 2011
-
Rheumatoid arthritis tofacitinib [ID526]: draft scope for consultation (pre-referral) - November 2011
-
Rheumatoid arthritis tofacitinib [ID526]: provisional matrix (pre-referral) - November 2011
-
Rheumatoid arthritis tofacitinib [ID526]: provisional matrix (pre-referral) - November 2011
-